Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Express Scripts
Boehringer Ingelheim
Colorcon
AstraZeneca
Cerilliant
Cipla
Queensland Health
QuintilesIMS
Johnson and Johnson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,338,732

« Back to Dashboard

Summary for Patent: 5,338,732
Title: Megestrol acetate formulation
Abstract:The present invention relates to a novel oral pharmaceutical composition of micronized megestrol acetate at a concentration of 15 to 150 mg/mL comprising polysorbate at a concentration of 0.005% to 0.015% weight/volume and polyethylene glycol at a concentration of 5-30% weight/volume which composition forms a stable flocculated suspension in water. The invention further comprises the micronized megestrol acetate formulation described above with added preservatives, buffers, sweeteners and flavoring agents.
Inventor(s): Atzinger; Anne E. (Lebanon, IN), Bequette; Robert J. (Evansville, IN), Davis; Robert E. (Evansville, IN)
Assignee: Bristol-Myers Squibb Company (New York, NY)
Application Number:07/882,218
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 5,338,732

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,338,732

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2071141 ➤ Subscribe
China 1067580 ➤ Subscribe
China 1038904 ➤ Subscribe
Czech Republic 9201853 ➤ Subscribe
Czech Republic 289620 ➤ Subscribe
Germany 69213836 ➤ Subscribe
Denmark 0519351 ➤ Subscribe
European Patent Office 0519351 ➤ Subscribe
Spain 2091977 ➤ Subscribe
Finland 922764 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Moodys
Baxter
Deloitte
Chubb
Federal Trade Commission
Citi
Medtronic
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot